Per Falholt (born 1958) is a Danish biotechnology business-executive at Novo Nordisk A/S. As Chief Science Officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.

He is the founder of Per Falholt Global R&D Advisory Services

Education

M.Sc., Chemical Engineering, Technical University of Denmark (DTU). 

Career

Falholt started his career as a research chemist at Novo Nordisk A/S. Through various managerial positions, developing products for the detergent industry, in 1995, Falholt became the Director for Application Technology in the company’s new enzyme development division.

In 1997, He migrated to Raleigh, N.C., to head the Novo’s U.S. application technology unit.
He returned to Denmark in 2000, becoming the Corporate Vice President of the Enzyme Development and Application division.

In 2010, he was appointed Honorary Professor at DTU’s Institute for Systems Biology. Subsequently, in 2013, he became Chairman of the Board at DTU’s Institute for Systems Biology. 

He is also Chairman of the Young Scientists association in Denmark.